author-photo

Luke Gaughan

Newcastle University

70

Papers

2764

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Correction to 'Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation'

2021 Nucleic Acids Research
Show All
- Source
- Cite
- Save
Citations (0)
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer.

2020 Nature Communications
Show All
- Source
- Cite
- Save
Citations (22)
Decision letter: A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth

2020 eLife
- Ivan Topisirovic
- Luke Gaughan
Show All
- Source
- Cite
- Save
Citations (0)
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

2019 Nucleic Acids Research
Show All
- Source
- Cite
- Save
Citations (16)
The pioneering role of GATA2 in androgen receptor variant regulation is controlled by bromodomain and extraterminal proteins in castrate-resistant prostate cancer

2019 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (6)
Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance.

2019 Oncogene
Show All
- Source
- Cite
- Save
Citations (1)
The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (8)
Abstract 3826: CCS1477, a potent and selective p300/CBP bromodomain inhibitor, is targeted & differentiated from BET inhibitors in prostate cancer cell linesin vitro

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3

2018 Journal of Cell Science
Show All
- Source
- Cite
- Save
Citations (10)
Abstract 3991: Novel small molecule inhibitors of p300/CBP down-regulate androgen receptor (AR) and c-Myc for the treatment of prostate cancer and beyond

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)